🇺🇸 Febuxostat 40 mg in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Apnoea — 1 report (10%)
  2. Cardiac Arrest — 1 report (10%)
  3. Cardio-Respiratory Arrest — 1 report (10%)
  4. Diarrhoea — 1 report (10%)
  5. Hypersensitivity — 1 report (10%)
  6. Myopathy — 1 report (10%)
  7. Nausea — 1 report (10%)
  8. Pruritus Generalised — 1 report (10%)
  9. Rash Papular — 1 report (10%)
  10. Rash Pruritic — 1 report (10%)

Source database →

Febuxostat 40 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Febuxostat 40 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Febuxostat 40 mg in United States?

Ardea Biosciences, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.